We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Sign Up For News Alerts

To automatically receive Genentech press release e-mail alerts, enter your e-mail address and click on the Subscribe button.


We Respect Your Privacy

Review our Privacy Policy.


Unsubscribe

To cancel the Genentech e-mail alert service, please click here.